메뉴 건너뛰기




Volumn 94, Issue 6, 2015, Pages

Cancer risk in HBV patients with statin and metformin use a population-based cohort study

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN;

EID: 84928581744     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000462     Document Type: Article
Times cited : (72)

References (65)
  • 1
    • 14844297739 scopus 로고    scopus 로고
    • Chronic hepatitis b virus infection and mortality from non-liver causes: Results from the haimen city cohort study
    • Chen G, Lin W, Shen F, et al. Chronic hepatitis B virus infection and mortality from non-liver causes: results from the Haimen City cohort study. Int J Epidemiol. 2005; 34: 132-137
    • (2005) Int J Epidemiol , vol.34 , pp. 132-137
    • Chen, G.1    Lin, W.2    Shen, F.3
  • 3
    • 0036239832 scopus 로고    scopus 로고
    • Hmg-coa reductase inhibitors and the malignant cell: The statin family of drugs as triggers of tumor-specific apoptosis
    • Wong WW, Dimitroulakos J, Minden MD, et al. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia. 2002; 16: 508-519
    • (2002) Leukemia , vol.16 , pp. 508-519
    • Wong, W.W.1    Dimitroulakos, J.2    Minden, M.D.3
  • 4
    • 0037062481 scopus 로고    scopus 로고
    • 3-hydroxy-3-methylglutaryl coa reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of rho gtpase/p21 signaling pathway: Implications for diabetic nephropathy
    • Danesh FR, Sadeghi MM, Amro N, et al. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway: implications for diabetic nephropathy. Proc Nat Acad Sci U S A. 2002; 99: 8301-8305
    • (2002) Proc Nat Acad Sci U S A. , vol.99 , pp. 8301-8305
    • Danesh, F.R.1    Sadeghi, M.M.2    Amro, N.3
  • 5
    • 0141615830 scopus 로고    scopus 로고
    • 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors decrease fas ligand expression and cytotoxicity in activated human t lymphocytes
    • Blanco-Colio LM, Munoz-Garcia B, Martin-Ventura JL, et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes. Circulation. 2003; 23: 1506-1513
    • (2003) Circulation , vol.23 , pp. 1506-1513
    • Blanco-Colio, L.M.1    Munoz-Garcia, B.2    Martin-Ventura, J.L.3
  • 6
    • 0035572718 scopus 로고    scopus 로고
    • Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors
    • Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscl Thrombo Vascul Biol. 2001; 21: 1712-1719
    • (2001) Arterioscl Thrombo Vascul Biol , vol.21 , pp. 1712-1719
    • Takemoto, M.1    Liao, J.K.2
  • 7
    • 0344406230 scopus 로고    scopus 로고
    • Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models
    • Shibata MA, Kavanaugh C, Shibata E, et al. Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models. Carcinogenesis. 2003; 24: 453-459
    • (2003) Carcinogenesis , vol.24 , pp. 453-459
    • Shibata, M.A.1    Kavanaugh, C.2    Shibata, E.3
  • 8
    • 0033529171 scopus 로고    scopus 로고
    • Lovastatin-mediated g1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-coa reductase
    • Rao S, Porter DC, Chen X, et al. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proc Nat Acad Sci U S A. 1999; 96: 7797-7802
    • (1999) Proc Nat Acad Sci U S A. , vol.96 , pp. 7797-7802
    • Rao, S.1    Porter, D.C.2    Chen, X.3
  • 9
    • 0028034956 scopus 로고
    • Effect of simvastatin, an inhibitor of hydroxy-methylglutaryl coenzyme a reductase, on the growth of human ito cells
    • Mallat A, Preaux AM, Blazejewski S, et al. Effect of simvastatin, an inhibitor of hydroxy-methylglutaryl coenzyme A reductase, on the growth of human Ito cells. Hepatology. 1994; 20: 1589-1594
    • (1994) Hepatology , vol.20 , pp. 1589-1594
    • Mallat, A.1    Preaux, A.M.2    Blazejewski, S.3
  • 11
    • 84863837081 scopus 로고    scopus 로고
    • Lipid metabolism in cancer
    • Santos CR, Schulze A. Lipid metabolism in cancer. FEBS J. 2012; 279: 2610-2623
    • (2012) FEBS J. , vol.279 , pp. 2610-2623
    • Santos, C.R.1    Schulze, A.2
  • 12
    • 0842321807 scopus 로고    scopus 로고
    • Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
    • El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004; 126: 460-468
    • (2004) Gastroenterology , vol.126 , pp. 460-468
    • El-Serag, H.B.1    Tran, T.2    Everhart, J.E.3
  • 14
    • 77956210076 scopus 로고    scopus 로고
    • Inhibition of stearoylcoa desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells
    • Hess D, Chisholm JW, Igal RA. Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells. PLoS One. 2010; 5: e11394
    • (2010) PLoS One , vol.5 , pp. e11394
    • Hess, D.1    Chisholm, J.W.2    Igal, R.A.3
  • 15
    • 0031053093 scopus 로고    scopus 로고
    • Lovastatin induction of cyclindependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion
    • Gray-Bablin J, Rao S, Keyomarsi K. Lovastatin induction of cyclindependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion. Cancer Res. 1997; 57: 604-609
    • (1997) Cancer Res , vol.57 , pp. 604-609
    • Gray-Bablin, J.1    Rao, S.2    Keyomarsi, K.3
  • 16
    • 0032487933 scopus 로고    scopus 로고
    • Lovastatin mediated g1 arrest in normal and tumor breast cells is through inhibition of cdk2 activity and redistribution of p21 and p27, independent of p53
    • Rao S, Lowe M, Herliczek TW, et al. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53. Oncogene. 1998; 17: 2393-2402
    • (1998) Oncogene , vol.17 , pp. 2393-2402
    • Rao, S.1    Lowe, M.2    Herliczek, T.W.3
  • 17
    • 39549117982 scopus 로고    scopus 로고
    • Fatty acid synthase gene is upregulated by hypoxia via activation of akt and sterol regulatory element binding protein-1
    • Furuta E, Pai SK, Zhan R, et al. Fatty acid synthase gene is upregulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res. 2008; 68: 1003-1011
    • (2008) Cancer Res , vol.68 , pp. 1003-1011
    • Furuta, E.1    Pai, S.K.2    Zhan, R.3
  • 18
    • 80054078528 scopus 로고    scopus 로고
    • Statin prescriptions and breast cancer recurrence risk: A danish nationwide prospective cohort study
    • Ahern TP, Pedersen L, Tarp M, et al. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Nat Cancer Inst. 2011; 103: 1461-1468
    • (2011) J Nat Cancer Inst , vol.103 , pp. 1461-1468
    • Ahern, T.P.1    Pedersen, L.2    Tarp, M.3
  • 19
    • 78049523865 scopus 로고    scopus 로고
    • Effect of statin therapy on colorectal cancer
    • Bardou M, Barkun A, Martel M. Effect of statin therapy on colorectal cancer. Gut. 2010; 59: 1572-1585
    • (2010) Gut , vol.59 , pp. 1572-1585
    • Bardou, M.1    Barkun, A.2    Martel, M.3
  • 20
    • 29944446607 scopus 로고    scopus 로고
    • Statins and cancer risk: A meta-Analysis
    • Dale KM, Coleman CI, Henyan NN, et al. Statins and cancer risk: a meta-Analysis. JAMA. 2006; 295: 74-80
    • (2006) JAMA , vol.295 , pp. 74-80
    • Dale, K.M.1    Coleman, C.I.2    Henyan, N.N.3
  • 21
    • 34548019063 scopus 로고    scopus 로고
    • Statins and the risk of colorectal cancer: A meta-Analysis of 18 studies involving more than 1.5 million patients
    • Bonovas S, Filioussi K, Flordellis CS, et al. Statins and the risk of colorectal cancer: a meta-Analysis of 18 studies involving more than 1.5 million patients. J Clin Oncol. 2007; 25: 3462-3468
    • (2007) J Clin Oncol , vol.25 , pp. 3462-3468
    • Bonovas, S.1    Filioussi, K.2    Flordellis, C.S.3
  • 22
    • 69549097703 scopus 로고    scopus 로고
    • New users of metformin are at low risk of incident cancer: A cohort study among people with type 2 diabetes
    • Libby G, Donnelly LA, Donnan PT, et al. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care. 2009; 32: 1620-1625
    • (2009) Diabetes Care , vol.32 , pp. 1620-1625
    • Libby, G.1    Donnelly, L.A.2    Donnan, P.T.3
  • 23
    • 78649302320 scopus 로고    scopus 로고
    • Metformin and cancer risk in diabetic patients: A systematic review and meta-Analysis
    • Decensi A, Puntoni M, Goodwin P, et al. Metformin and cancer risk in diabetic patients: a systematic review and meta-Analysis. Cancer Prevent Res. 2010; 3: 1451-1461
    • (2010) Cancer Prevent Res , vol.3 , pp. 1451-1461
    • Decensi, A.1    Puntoni, M.2    Goodwin, P.3
  • 24
    • 84858695046 scopus 로고    scopus 로고
    • Cancer risk in diabetic patients treated with metformin: A systematic review and meta-Analysis
    • Noto H, Goto A, Tsujimoto T, et al. Cancer risk in diabetic patients treated with metformin: a systematic review and meta-Analysis. PLoS One. 2012; 7: e33411
    • (2012) PLoS One , vol.7 , pp. e33411
    • Noto, H.1    Goto, A.2    Tsujimoto, T.3
  • 25
    • 84862064131 scopus 로고    scopus 로고
    • Statin use as a moderator of metformin effect on risk for prostate cancer among type 2 diabetic patients
    • Lehman DM, Lorenzo C, Hernandez J, et al. Statin use as a moderator of metformin effect on risk for prostate cancer among type 2 diabetic patients. Diabetes Care. 2012; 35: 1002-1007
    • (2012) Diabetes Care , vol.35 , pp. 1002-1007
    • Lehman, D.M.1    Lorenzo, C.2    Hernandez, J.3
  • 26
    • 84930352654 scopus 로고    scopus 로고
    • Combination of metformin and statins significantly enhanced the local radio therapeutic effect and attenuated the lung metastasis of lewis lung carcinoma (llc) animal model
    • Wu SY, Lin KC, Chiou JF, et al. Combination of metformin and statins significantly enhanced the local radio therapeutic effect and attenuated the lung metastasis of lewis lung carcinoma (LLC) animal model. Int J Rad Oncol Biol Phys. 2014; 90: S800-S801
    • (2014) Int J Rad Oncol Biol Phys , vol.90 , pp. S800-S801
    • Wu, S.Y.1    Lin, K.C.2    Chiou, J.F.3
  • 27
    • 84862746989 scopus 로고    scopus 로고
    • Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 us centers
    • Darwish Murad S, Kim WR, Harnois DM, et al. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology. 2012; 143: 88-98
    • (2012) Gastroenterology , vol.143 , pp. 88-98
    • Darwish Murad, S.1    Kim, W.R.2    Harnois, D.M.3
  • 28
    • 20444461067 scopus 로고    scopus 로고
    • Metformin and reduced risk of cancer in diabetic patients
    • Evans JM, Donnelly LA, Emslie-Smith AM, et al. Metformin and reduced risk of cancer in diabetic patients. BMJ. 2005; 330: 1304-1305
    • (2005) BMJ , vol.330 , pp. 1304-1305
    • Evans, J.M.1    Donnelly, L.A.2    Emslie-Smith, A.M.3
  • 29
    • 67650169923 scopus 로고    scopus 로고
    • Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease
    • Donadon V, Balbi M, Ghersetti M, et al. Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease. World J Gastroenterol. 2009; 15: 2506-2511
    • (2009) World J Gastroenterol , vol.15 , pp. 2506-2511
    • Donadon, V.1    Balbi, M.2    Ghersetti, M.3
  • 30
    • 77954365681 scopus 로고    scopus 로고
    • Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
    • Donadon V, Balbi M, Mas MD, et al. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease. Liver Int. 2010; 30: 750-758
    • (2010) Liver Int , vol.30 , pp. 750-758
    • Donadon, V.1    Balbi, M.2    Mas, M.D.3
  • 31
    • 77951006620 scopus 로고    scopus 로고
    • Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma
    • Hassan MM, Curley SA, Li D, et al. Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer. 2010; 116: 1938-1946
    • (2010) Cancer , vol.116 , pp. 1938-1946
    • Hassan, M.M.1    Curley, S.A.2    Li, D.3
  • 32
    • 84855432249 scopus 로고    scopus 로고
    • Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with antidiabetic therapy: A population-based cohort study
    • Lai SW, Chen PC, Liao KF, et al. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with antidiabetic therapy: a population-based cohort study. Am J Gastroenterol. 2012; 107: 46-52
    • (2012) Am J Gastroenterol , vol.107 , pp. 46-52
    • Lai, S.W.1    Chen, P.C.2    Liao, K.F.3
  • 33
    • 65349175605 scopus 로고    scopus 로고
    • Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
    • Alimova IN, Liu B, Fan Z, et al. Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell cycle. 2009; 8: 909-915
    • (2009) Cell Cycle , vol.8 , pp. 909-915
    • Alimova, I.N.1    Liu, B.2    Fan, Z.3
  • 34
    • 60749108023 scopus 로고    scopus 로고
    • The antidiabetic drug metformin suppresses her2 (erbb-2) oncoprotein overexpression via inhibition of the mtor effector p70s6k1 in human breast carcinoma cells
    • Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA. The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells. Cell cycle. 2009; 8: 88-96
    • (2009) Cell Cycle , vol.8 , pp. 88-96
    • Vazquez-Martin, A.1    Oliveras-Ferraros, C.2    Menendez, J.A.3
  • 35
    • 70450021431 scopus 로고    scopus 로고
    • Mtor inhibitors and the antidiabetic biguanide metformin: New insights into the molecular management of breast cancer resistance to the her2 tyrosine kinase inhibitor lapatinib (tykerb
    • Menendez J.A.
    • Vazquez-Martin A, Oliveras-Ferraros C, del Barco S, et al. Menendez JA. mTOR inhibitors and the antidiabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (Tykerb). Clin Translational Oncol. 2009; 11: 455-459
    • (2009) Clin Translational Oncol , vol.11 , pp. 455-459
    • Vazquez-Martin, A.1    Oliveras-Ferraros, C.2    Del Barco, S.3
  • 37
    • 1642328617 scopus 로고    scopus 로고
    • Stimulation of the amp-Activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398
    • Browne GJ, Finn SG, Proud CG. Stimulation of the AMP-Activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. J Biol Chemistry. 2004; 279: 12220-12231
    • (2004) J Biol Chemistry , vol.279 , pp. 12220-12231
    • Browne, G.J.1    Finn, S.G.2    Proud, C.G.3
  • 38
    • 0034644525 scopus 로고    scopus 로고
    • Tor, a central controller of cell growth
    • Schmelzle T, Hall MN. TOR, a central controller of cell growth. Cell. 2000; 103: 253-262
    • (2000) Cell , vol.103 , pp. 253-262
    • Schmelzle, T.1    Hall, M.N.2
  • 39
    • 0345167800 scopus 로고    scopus 로고
    • Tsc2 mediates cellular energy response to control cell growth and survival
    • Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 2003; 115: 577-590
    • (2003) Cell , vol.115 , pp. 577-590
    • Inoki, K.1    Zhu, T.2    Guan, K.L.3
  • 40
    • 42949139481 scopus 로고    scopus 로고
    • Ampk phosphorylation of raptor mediates a metabolic checkpoint
    • Gwinn DM, Shackelford DB, Egan DF, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008; 30: 214-226
    • (2008) Mol Cell , vol.30 , pp. 214-226
    • Gwinn, D.M.1    Shackelford, D.B.2    Egan, D.F.3
  • 41
    • 13344270279 scopus 로고    scopus 로고
    • Diabetes mellitus and breast cancer
    • Wolf I, Sadetzki S, Catane R, et al. Diabetes mellitus and breast cancer. Lancet Oncol. 2005; 6: 103-111
    • (2005) Lancet Oncol , vol.6 , pp. 103-111
    • Wolf, I.1    Sadetzki, S.2    Catane, R.3
  • 42
    • 21244485747 scopus 로고    scopus 로고
    • Type-ii diabetes and pancreatic cancer: A meta-Analysis of 36 studies
    • Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, et al. Type-II diabetes and pancreatic cancer: a meta-Analysis of 36 studies. Br J Cancer. 2005; 92: 2076-2083
    • (2005) Br J Cancer , vol.92 , pp. 2076-2083
    • Huxley, R.1    Ansary-Moghaddam, A.2    Berrington De Gonzalez, A.3
  • 43
    • 27944450832 scopus 로고    scopus 로고
    • Diabetes mellitus and risk of colorectal cancer: A meta-Analysis
    • Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-Analysis. J Nat Cancer Inst. 2005; 97: 1679-1687
    • (2005) J Nat Cancer Inst , vol.97 , pp. 1679-1687
    • Larsson, S.C.1    Orsini, N.2    Wolk, A.3
  • 44
    • 34249948987 scopus 로고    scopus 로고
    • Diabetes mellitus and risk of endometrial cancer: A meta-Analysis
    • Friberg E, Orsini N, Mantzoros CS, et al. Diabetes mellitus and risk of endometrial cancer: a meta-Analysis. Diabetologia. 2007; 50: 1365-1374
    • (2007) Diabetologia , vol.50 , pp. 1365-1374
    • Friberg, E.1    Orsini, N.2    Mantzoros, C.S.3
  • 45
    • 68149131125 scopus 로고    scopus 로고
    • Obesity related hyperinsulinaemia and hyperglycaemia and cancer development
    • Becker S, Dossus L, Kaaks R. Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Arc Physiol Biochem. 2009; 115: 86-96
    • (2009) Arc Physiol Biochem , vol.115 , pp. 86-96
    • Becker, S.1    Dossus, L.2    Kaaks, R.3
  • 46
    • 22244446505 scopus 로고    scopus 로고
    • The mammalian unfolded protein response
    • Schroder M, Kaufman RJ. The mammalian unfolded protein response. Ann Rev Biochem. 2005; 74: 739-789
    • (2005) Ann Rev Biochem , vol.74 , pp. 739-789
    • Schroder, M.1    Kaufman, R.J.2
  • 47
    • 66249092010 scopus 로고    scopus 로고
    • Chemical genomics identifies the unfolded protein response as a target for selective cancer cell killing during glucose deprivation
    • Saito S, Furuno A, Sakurai J, et al. Chemical genomics identifies the unfolded protein response as a target for selective cancer cell killing during glucose deprivation. Cancer Res. 2009; 69: 4225-4234
    • (2009) Cancer Res , vol.69 , pp. 4225-4234
    • Saito, S.1    Furuno, A.2    Sakurai, J.3
  • 48
    • 0020040832 scopus 로고
    • Metabolic immunodepression and metabolic immunotherapy: An attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances
    • Dilman VM, Berstein LM, Ostroumova MN, et al. Metabolic immunodepression and metabolic immunotherapy: an attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances. Oncology. 1982; 39: 13-19
    • (1982) Oncology , vol.39 , pp. 13-19
    • Dilman, V.M.1    Berstein, L.M.2    Ostroumova, M.N.3
  • 49
    • 67650096912 scopus 로고    scopus 로고
    • Enhancing cd8 t-cell memory by modulating fatty acid metabolism
    • Pearce EL, Walsh MC, Cejas PJ, et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature. 2009; 460: 103-107
    • (2009) Nature , vol.460 , pp. 103-107
    • Pearce, E.L.1    Walsh, M.C.2    Cejas, P.J.3
  • 50
    • 70350236538 scopus 로고    scopus 로고
    • Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission
    • Hirsch HA, Iliopoulos D, Tsichlis PN, et al. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res. 2009; 69: 7507-7511
    • (2009) Cancer Res , vol.69 , pp. 7507-7511
    • Hirsch, H.A.1    Iliopoulos, D.2    Tsichlis, P.N.3
  • 51
    • 79954460690 scopus 로고    scopus 로고
    • The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells
    • Vazquez-Martin A, Oliveras-Ferraros C, Del Barco S, et al. The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells. Breast Cancer Res Treat. 2011; 126: 355-364
    • (2011) Breast Cancer Res Treat , vol.126 , pp. 355-364
    • Vazquez-Martin, A.1    Oliveras-Ferraros, C.2    Del Barco, S.3
  • 52
    • 77957005003 scopus 로고    scopus 로고
    • Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (emt) status
    • Vazquez-Martin A, Oliveras-Ferraros C, Cufi S, et al. Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status. Cell Cycle. 2010; 9: 3807-3814
    • (2010) Cell Cycle , vol.9 , pp. 3807-3814
    • Vazquez-Martin, A.1    Oliveras-Ferraros, C.2    Cufi, S.3
  • 53
    • 43049165453 scopus 로고    scopus 로고
    • The epithelial-mesenchymal transition generates cells with properties of stem cells
    • Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133: 704-715
    • (2008) Cell , vol.133 , pp. 704-715
    • Mani, S.A.1    Guo, W.2    Liao, M.J.3
  • 54
    • 78649872745 scopus 로고    scopus 로고
    • Metformin against tgfbeta-induced epithelial-To-mesenchymal transition (emt): From cancer stem cells to aging-Associated fibrosis
    • Cufi S, Vazquez-Martin A, Oliveras-Ferraros C, et al. Metformin against TGFbeta-induced epithelial-To-mesenchymal transition (EMT): from cancer stem cells to aging-Associated fibrosis. Cell Cycle. 2010; 9: 4461-4468
    • (2010) Cell Cycle , vol.9 , pp. 4461-4468
    • Cufi, S.1    Vazquez-Martin, A.2    Oliveras-Ferraros, C.3
  • 55
    • 84863115964 scopus 로고    scopus 로고
    • Statins and the risk of hepatocellular carcinoma in patients with hepatitis b virus infection
    • Tsan YT, Lee CH, Wang JD, et al. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection. J Clin Oncol. 2012; 30: 623-630
    • (2012) J Clin Oncol , vol.30 , pp. 623-630
    • Tsan, Y.T.1    Lee, C.H.2    Wang, J.D.3
  • 56
    • 33745903898 scopus 로고    scopus 로고
    • Different anti-hcv profiles of statins and their potential for combination therapy with interferon
    • Ikeda M, Abe K, Yamada M, et al. Different anti-HCV profiles of statins and their potential for combination therapy with interferon. Hepatology. 2006; 44: 117-125
    • (2006) Hepatology , vol.44 , pp. 117-125
    • Ikeda, M.1    Abe, K.2    Yamada, M.3
  • 57
    • 79961218135 scopus 로고    scopus 로고
    • Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-Analysis of cohort studies
    • Wang C, Wang X, Gong G, et al. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-Analysis of cohort studies. Int J Cancer. 2012; 130: 1639-1648
    • (2012) Int J Cancer , vol.130 , pp. 1639-1648
    • Wang, C.1    Wang, X.2    Gong, G.3
  • 58
    • 33749031867 scopus 로고    scopus 로고
    • Diabetes mellitus and the risk of cancer: Results from a large-scale population-based cohort study in japan
    • Inoue M, Iwasaki M, Otani T, et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arc Internal Med. 2006; 166: 1871-1877
    • (2006) Arc Internal Med , vol.166 , pp. 1871-1877
    • Inoue, M.1    Iwasaki, M.2    Otani, T.3
  • 59
    • 33745556520 scopus 로고    scopus 로고
    • Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection
    • Lai MS, Hsieh MS, Chiu YH, et al. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology. 2006; 43: 1295-1302
    • (2006) Hepatology , vol.43 , pp. 1295-1302
    • Lai, M.S.1    Hsieh, M.S.2    Chiu, Y.H.3
  • 60
    • 34249880490 scopus 로고    scopus 로고
    • Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: A preliminary report
    • Torisu Y, Ikeda K, Kobayashi M, et al. Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: a preliminary report. Hepatol Res. 2007; 37: 517-523
    • (2007) Hepatol Res , vol.37 , pp. 517-523
    • Torisu, Y.1    Ikeda, K.2    Kobayashi, M.3
  • 61
    • 0036219298 scopus 로고    scopus 로고
    • Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C
    • Tazawa J, Maeda M, Nakagawa M, et al. Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C. Dig Dis Sci. 2002; 47: 710-715
    • (2002) Dig Dis Sci , vol.47 , pp. 710-715
    • Tazawa, J.1    Maeda, M.2    Nakagawa, M.3
  • 62
    • 78650710888 scopus 로고    scopus 로고
    • The relationship between new-onset diabetes mellitus and pancreatic cancer risk: A case-control study
    • Ben Q, Cai Q, Li Z, et al. The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study. Eur J Cancer. 2011; 47: 248-254
    • (2011) Eur J Cancer , vol.47 , pp. 248-254
    • Ben, Q.1    Cai, Q.2    Li, Z.3
  • 63
    • 33644759114 scopus 로고    scopus 로고
    • The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence
    • El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006; 4: 369-380
    • (2006) Clin Gastroenterol Hepatol , vol.4 , pp. 369-380
    • El-Serag, H.B.1    Hampel, H.2    Javadi, F.3
  • 64
    • 67349134980 scopus 로고    scopus 로고
    • Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: A prospective study in the european prospective investigation into cancer and nutrition (epic)-potsdam cohort
    • Heidemann C, Boeing H, Pischon T, et al. Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort. Eur J Epidemiol. 2009; 24: 281-288
    • (2009) Eur J Epidemiol , vol.24 , pp. 281-288
    • Heidemann, C.1    Boeing, H.2    Pischon, T.3
  • 65
    • 40049088464 scopus 로고    scopus 로고
    • Diabetes and endometrial cancer: An evaluation of the modifying effects of other known risk factors
    • Saltzman BS, Doherty JA, Hill DA, et al. Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors. Am J Epidemiol. 2008; 167: 607-614
    • (2008) Am J Epidemiol , vol.167 , pp. 607-614
    • Saltzman, B.S.1    Doherty, J.A.2    Hill, D.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.